Leah Solivan
CIK: 0002028705
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PETS
PETMED EXPRESS INC
Director
Discretionary Trading P&L
Holdings
About Solivan Leah
Solivan Leah (SEC CIK 0002028705) files insider reports with the SEC as Director of PETMED EXPRESS INC (PETS).
Signal8 holds 1 ownership filing by Solivan Leah, a Form 4, filed on Nov 3, 2025. Those filings report 1 transaction, the latest on Oct 30, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Solivan Leah's filings is in DELRAY BEACH, FL.
Recent filings by Solivan Leah
- Oct 30, 2025: Grant or award of PETS shares (Form 4, code A).
Other insiders filing for PETMED EXPRESS INC (PETS)
- Willard Jeffrey Allen, CEO and President
- Elkeles Tamar, Director
- Campbell Leslie C.G., Interim CEO and President
- LaCamp James, Director
- Batushansky Peter, Director
- Mennen Justin L., Director